Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ronald W. Barrett currently holds 15,500 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald W. Barrett has been a net seller of JANX stock. They have purchased $80.4K and sold $6.2M worth of shares.
Ronald W. Barrett's most recent insider trade was on Jun 11, 2026, when they sold 15,500 shares at $0.00 per share.
Ronald W. Barrett serves as Executive at Janux Therapeutics, Inc. (JANX). They have executed 1074 insider transactions totaling $6.3M over their tenure at the company.
Ronald W. Barrett holds the position of Executive at Janux Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Ronald W. Barrett has shown a selling trading pattern, with $80.4K in total purchases and $6.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ronald W. Barrett was on Dec 4, 2017, when they sold $349.7K worth of CNCE shares. This transaction involved 14,156 shares at $24.70 per share.
Ronald W. Barrett currently owns 15,500 shares of Janux Therapeutics, Inc. (JANX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ronald W. Barrett's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ronald W. Barrett has 1074 Form 4 filings on record as an insider at Janux Therapeutics, Inc..
Set alerts for Ronald W. Barrett and 40,000+ other insiders.